“A lot of insurance payers interpreted this to mean that in order to get covered for the treatment, you also needed to start a new oral antidepressant.” Those requirements can make it more difficult ...

PE: How does Spravato’s availability as a monotherapy enhance your ability to personalize treatment plans for patients with ... as reflected in numerous patient experiences. For instance, one patient ...

A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with ...

“Spravato ® is now available as a standalone treatment, meaning patients may experience improvements in depressive symptoms as early as 24 hours and at 28 days – without the need for daily ...

Spravato is now the first stand-alone therapy for treatment-resistant depression, for patients who haven't responded to oral antidepressants.

“Spravato is now available as a standalone treatment, meaning patients may experience improvements in depressive symptoms as early as 24 hours and at 28 days, without the need for daily oral ...

"Spravato is now available as a standalone treatment, meaning patients may experience improvements in depressive symptoms as early as 24 hours and at 28 days -- without the need for daily oral ...

"SPRAVATO ® is now available as a standalone treatment, meaning patients may experience improvements in depressive symptoms as early as 24 hours and at 28 days – without the need for daily oral ...

"Spravato is now available as a stand-alone treatment, meaning patients may experience improvements in depressive symptoms as early as 24 hours and at 28 days -- without the need for daily oral ...

We are a REMS certified Spravato Treatment Center. For over 25 years, I've cared for people of all ages impacted by traumatic life experiences. I strive to meet mental and behavioral health needs ...